Retour sur lavenir.net
   XIOR 27.950 € (-0,53 %)     LOTUS BAKERIES 10 800.000 € (-1,46 %)     CARE PROPERTY INV. 12.640 € (-0,16 %)     KINEPOLIS GROUP 38.650 € (-0,39 %)     KBC ANCORA 87.200 € (+2,71 %)     EKOPAK 3.710 € (-7,25 %)     MONTEA 67.900 € (-0,73 %)     ARGENX SE 760.200 € (+0,88 %)     AB INBEV 71.480 € (+0,42 %)     NYXOAH 1.384 € (+0,73 %)     AGFA-GEVAERT 0.395 € (+3,82 %)     PROXIMUS 6.060 € (-1,14 %)     CENERGY 21.260 € (+4,52 %)     DEME GROUP 168.800 € (-0,35 %)     CFE 11.450 € (+1,33 %)     BARCO 7.795 € (+0,19 %)     BEKAERT 41.250 € (+0,61 %)     VGP 81.100 € (+1,37 %)     SOLVAY 25.980 € (+0,70 %)     D'IETEREN GROUP 172.400 € (-3,04 %)     ELIA GROUP 137.600 € (-1,08 %)     FAGRON 23.850 € (+0,42 %)     HOME INVEST BE. 19.460 € (-0,21 %)     ACKERMANS V.HAAREN 268.600 € (+0,37 %)     ORANGE BELGIUM 21.700 € (-1,36 %)     ASCENCIO 51.500 € (-0,19 %)     VAN DE VELDE 29.600 € (-1,99 %)     KBC 122.350 € (+2,38 %)     JENSEN-GROUP 84.200 € (+0,72 %)     VASTNED 29.300 € (-0,85 %)     ECONOCOM GROUP 1.465 € (+1,03 %)     SIPEF 92.400 € (0,00 %)     CMB.TECH 13.620 € (+1,95 %)     ONWARD MEDICAL 2.485 € (+1,22 %)     SOFINA 229.200 € (+0,44 %)     WDP 22.100 € (-1,34 %)     ENERGYVISION 14.800 € (+0,27 %)     EVS 26.900 € (+0,19 %)     DECEUNINCK 2.175 € (+0,69 %)     GIMV 44.550 € (+0,11 %)     RETAIL ESTATES 67.600 € (-0,88 %)     ONTEX GROUP 2.210 € (-2,86 %)     BPOST 1.570 € (-1,13 %)     AGEAS 70.800 € (-0,42 %)     COLRUYT 37.940 € (-1,86 %)     GBL 77.200 € (+0,13 %)     UCB 243.900 € (+2,48 %)     WERELDHAVE BELGIUM 52.400 € (0,00 %)     VIOHALCO 17.220 € (+2,26 %)     SYENSQO 69.300 € (+0,22 %)     RECTICEL 12.020 € (+4,16 %)     TUBIZE-FIN 209.000 € (+2,65 %)     TESSENDERLO 20.500 € (-0,97 %)     TITAN S.A. 48.800 € (+1,33 %)     IBA 16.740 € (-0,36 %)     CIE BOIS SAUVAGE 301.000 € (+0,33 %)     SHURGARD 25.200 € (-3,45 %)     AEDIFICA 69.900 € (-0,71 %)     BIOTALYS 2.980 € (+0,17 %)     BREDERODE 103.000 € (0,00 %)  
   NSI N.V. 16.380 € (-1,56 %)     SHELL PLC 38.210 € (+0,79 %)     CAPITAL B 0.507 € (+6,13 %)     ATLAND 33.600 € (+0,30 %)     GENFIT 14.060 € (+3,69 %)     RELX 28.900 € (-2,69 %)     ABIONYX PHARMA 1.864 € (+1,19 %)     TKH GROUP 42.980 € (+1,27 %)     CORBION 19.410 € (-1,87 %)     MAISONS DU MONDE 0.188 € (-2,19 %)     LEGRAND 137.250 € (+1,59 %)     CREDIT AGRICOLE 18.105 € (+0,98 %)     TIKEHAU CAPITAL 17.360 € (-2,03 %)     CARBIOS 6.800 € (+23,41 %)     ARCELORMITTAL SA 57.860 € (-0,65 %)     ABN AMRO BANK N.V. 38.190 € (+2,00 %)     PROSUS 38.495 € (-3,70 %)     DSM FIRMENICH AG 83.980 € (-2,12 %)     WOLTERS KLUWER 60.000 € (-2,31 %)     PLANISWARE 20.000 € (-4,08 %)     ALTEN 55.300 € (-2,12 %)     BNP PARIBAS ACT.A 105.160 € (+1,80 %)     THEON INTERNAT 32.980 € (+2,93 %)     SEMCO TECHNOLOGIES 43.200 € (+4,10 %)     KAUFMAN ET BROAD 26.150 € (+1,16 %)     BILENDI 15.320 € (+2,68 %)     WORLDLINE 10.160 € (+2,77 %)     X-FAB 7.450 € (+7,74 %)     AEGON 8.020 € (+0,35 %)     ATOS GROUP 28.620 € (-5,23 %)     PEUGEOT INVEST 56.100 € (+1,08 %)     ASML HOLDING 1 593.400 € (+4,77 %)     AUBAY 53.000 € (-2,03 %)     IMCD 87.960 € (-0,43 %)     UNILEVER 53.440 € (-2,21 %)     SIRIUS MEDIA 0.640 € (-3,00 %)     BUREAU VERITAS 27.060 € (-1,53 %)     VICAT 60.800 € (-0,16 %)     AKZO NOBEL 57.160 € (-0,45 %)     INPOST 15.500 € (+0,26 %)     L'OREAL 378.750 € (-0,43 %)     BENETEAU 6.100 € (-0,97 %)     UMG 18.500 € (+0,27 %)     ORANGE 16.185 € (-1,52 %)     WENDEL 80.050 € (-0,87 %)     STMICROELECTRONICS 57.250 € (+4,26 %)     ARCADIS 34.380 € (-0,87 %)     BAM GROEP KON 11.670 € (+2,01 %)     JCDECAUX 21.860 € (-1,44 %)     LAKEFRONT BIOTHER. 25.640 € (-0,23 %)     AIR LIQUIDE 176.520 € (-0,66 %)     AXA 44.790 € (+0,07 %)     BASIC-FIT 30.680 € (-0,78 %)     CARREFOUR 16.545 € (-1,16 %)     HEINEKEN 76.920 € (-0,44 %)     SLIGRO FOOD GROUP 11.520 € (-3,52 %)     HEXAOM 27.200 € (-2,86 %)     KPN KON 4.247 € (-1,14 %)     GETLINK SE 18.790 € (+0,05 %)     MAUNA KEA TECH 0.170 € (+6,25 %)  
News Réglementées
15/07/2026 15:10

Xryma Plc Announces Approval and Publication of its Prospectus for Admission to Trading on Euronext Paris

EQS-News: Xryma Plc / Key word(s): Miscellaneous/Private Equity
Xryma Plc Announces Approval and Publication of its Prospectus for Admission to Trading on Euronext Paris

15.07.2026 / 15:10 CET/CEST
The issuer is solely responsible for the content of this announcement.


Χρήμα: Greek for "Money"

NICOSIA, Cyprus, July 15, 2026 /PRNewswire/ -- Xryma Plc (the "Company") (Euronext Paris: XRY); (ISIN: CY0200861017), a banktech group providing regulated cross-border open banking, international transactional banking and real-time EU and UK payment services, whilst also independently offering banking software and technology to third party banks and Financial Institutions (FIs), is pleased to announce that its competent authority, the Cyprus Securities and Exchange Commission ("CySEC"), has approved the prospectus prepared in connection with the admission of the Company's ordinary shares to trading on the regulated market of Euronext Paris Stock Exchange, with trading expected to commence at market open on the 24th July 2026. The prospectus will now be passported to France via the Autorité des marchés financiers (AMF).

Xryma Plc Announces Approval and Publication of its Prospectus for Admission to Trading on Euronext Paris

Subject to Euronext Paris' approval to admit Xryma Plc to the list, 110,079,450 ordinary shares will be quoted in Euro € under the ticker symbol "XRY". Subject to the satisfaction of customary closing conditions and final approvals, 24th July 2026 has been set as the expected first day of trading on the Euronext Paris Stock Exchange.

The admission will take the form of a technical (direct) listing. No new shares will be issued, no existing shares are being offered for sale by the Company, and no capital will be raised in connection with the admission.

Since its founding, Xryma Plc has built a comprehensive, 7 years continuously profitable, regulated payments platform that simplifies how merchants accept, move and settle money, across multiple payment channels, through a single connection. The expected listing marks a significant milestone in the Company's development and reflects the scale the Xryma Group has reached as an infrastructure-led, regulated banktech business.

The Xryma Group operates a scalable business model generating fee-based, transaction-driven revenue of €53.4 million in FY25 (including other income). In the same period, the Xryma Group handled approximately €4.0 billion in own processing volume, while its Probanx® software services subsidiary processed €206.7 billion in SaaS volume on behalf of customer banks and FIs, monetised through software licensing rather than regulated product transactional fees.

Takis Taoushanis, Non-Executive Chairman of Xryma Plc, said:

"The approval of our Company's prospectus for admission to trading on Euronext Paris represents a significant achievement in our corporate journey. The Board of Directors has overseen a rigorous preparation process, and the transparency and governance disciplines of a leading European regulated market are aligned with the standards under which the Xryma Group already operates."

"This development is expected to strengthen our market position, support the continued expansion of our product portfolio, and create long-term value for our customers, partners, employees and shareholders. It also underscores Cyprus' growing role as an international business hub with global reach, supported by a professional services ecosystem that enables well-governed businesses to operate and grow across international markets."

Nikogiannis (John) Karantzis, Group Chief Executive Officer and Managing Director of Xryma Plc, said:

"Xryma Plc moves money across central banks, bank-to-bank, correspondent banks, ACH network, electronic money, card, cash, and stablecoin rails. The Company solves many of the challenges of today's fragmented global payments landscape. Built on a proprietary, regulated, full-stack ecosystem developed over the past 15 years, Xryma Plc is more than just a payments company. It has evolved into a deep financial infrastructure company that enables businesses to accept, move, and settle money globally through multiple payment channels on a single, unified platform."

"I am excited for the Company and its shareholders regarding the imminent listing on Euronext Paris, being one of the Top 5 exchange groups globally and a "premiere exchange". This admission is expected to further open our share register to further financial institutions, who already comprise 25% of our register, as well as like-minded technology investors, who can appreciate Xryma's unique value proposition."

Rationale for admission

Admission of Xryma Plc's shares to trading on Euronext Paris is expected to:

  • Increase awareness of the Xryma Group and its brands
  • Improve the liquidity of the Company's shares over time
  • Strengthen the Company's access to capital markets in support of future growth
  • Increase the transparency of the Company and its subsidiaries, supporting new and existing partnerships

Xryma Plc's senior management would like to thank the CySEC, AMF, Euronext Paris and all advisers who supported the cross-border listing process, including Aldebaran Advisors (Paris), All Invest Securities (Paris), CDB Global Securities (Nicosia), Morgan Lewis (Paris) and Chrysses Demetriades (Limassol). The expected admission sets an important precedent for Cypriot companies seeking similar listings on the French main market.

The Xryma Plc prospectus is available for viewing on the Xryma Group's investor relations website at https://www.xryma.com/investors.

About Xryma Plc

Xryma Plc [Euronext Paris: XRY] is a regulated European bank-tech group that develops banking technology via its Probanx® subsidiary and operates digital payment services underpinned by direct central-bank settlement. Xryma is one of the first non-bank participants authorised to connect directly to the Eurosystem's T2 RTGS and TIPS platforms. The Company holds Electronic Money Institution (EMI) authorisations in both the EU and the UK and offers multi-currency corporate accounts. Its open-banking service, PaidBy®, delivers one of the world's first cross-border, account-to-account, dynamic-currency-converting service for merchants, with instant local payments and next-business-day settlement in major and exotic currencies. Xryma is also the issuer of the upcoming electronic-money token XrymaCoin (XREUR).

Investor Relations Contact
Théo Martin
xryma@newcap.eu
+33 1 44 71 94 94
NewCap Investor Relations


Following is the official statutory announcement of Prospectus Release
--------------

ADVERTISEMENT

NOT FOR DISTRIBUTION OR ANNOUNCEMENT, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR ANNOUNCEMENT WOULD BE UNLAWFUL. IT IS PROHIBITED TO ISSUE, PUBLISH OR CIRCULATE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, WITHIN ANY JURISDICTION WHERE DOING SO WOULD VIOLATE THE LAWS OF SAID JURISDICTION.


Nicosia, July 15 2026


ANNOUNCEMENT
Approval and publication of the Prospectus of XRYMA PLC for the admission to trading on Euronext Paris of all ordinary shares of nominal value €0.07 each in the capital of XRYMA PLC

XRYMA PLC (the "Company") announces that on July 14, 2026 the Cyprus Securities and Exchange Commission (the "CySEC") approved the prospectus of the Company (the "Prospectus") regarding the admission to trading of the Company's ordinary shares (the "Shares") on the regulated market of Euronext Paris, with trading on an unconditional basis currently expected to commence on Friday, July 24, 2026 [indicative].

The Prospectus, as approved by CySEC, will be available to the general public without charge in electronic form at:

The admission of the Shares to trading on Euronext Paris is subject to the Company obtaining an approval by Euronext Paris.

Expected timetable of principal events for admission to trading

The timetable below is indicative and may be adjusted, including potential acceleration or extension:

Prospectus approval and publication: July 14, 2026

Expected commencement of trading of the Shares on Euronext Paris, if admission is approved: July 24, 2026 [indicative]

Contact for additional information:

For more information, investors can contact during business days and hours:

Media contact:
PR & Media team
E-Mail: media@xryma.com
Tel: +357-22015740

Investor Relations:
Investor Relations team
E-Mail: investors@xryma.com
Tel: +357-22015740

The Prospectus has been drawn-up in the form of a single document within the meaning of Article 6(3) of Regulation (EU) 2017/1129 of the European Parliament and of the Council of June 14, 2017 ("Prospectus Regulation"), and prepared on the basis of Annex 1 and Annex 11 of the Commission Delegated Regulation (EU) 2019/980 of March 14, 2019 supplementing the Prospectus Regulation as regards the format, content, scrutiny and approval of the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Commission Regulation (EC) No. 2004/809, and the Cyprus Public Offer and Prospectus Laws of 2005 to 2019 to the extent that they are valid after the entry into force of the Prospectus Regulation.

The Company has requested CySEC to notify the approved Prospectus in accordance with the Prospectus Regulation to the Autorité des marchés financiers.

This Prospectus has been approved by the CySEC, in its capacity as the competent authority in Cyprus within the meaning of the Prospectus Regulation. The CySEC only approves this Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the Prospectus Regulation. Such approval should not be considered as an endorsement of the quality of the Shares or of the Company. Investors should make their own assessment as to the suitability of investing in the Shares and should carefully study the Prospectus before making any investment decision related to the Shares in order to fully understand the potential risks and rewards associated with the decision to invest in the Shares.

THIS DOCUMENT IS NOT A PROSPECTUS BUT AN ADVERTISEMENT UNDER THE PROSPECTUS REGULATION AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISIONS REGARDING ANY SHARES REFERRED TO HEREIN BASED ON THIS ADVERTISEMENT.

Xryma Logo

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/xryma-plc-announces-approval-and-publication-of-its-prospectus-for-admission-to-trading-on-euronext-paris-302826456.html

rt.gif?NewsItemId=EN05124&Transmission_Id=202607150907PR_NEWS_EURO_ND__EN05124&DateId=20260715


15.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2366426  15.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière